Literature DB >> 8453859

Concentration-controlled versus concentration-defined clinical trials.

G Levy.   

Abstract

Mesh：

Year:  1993        PMID： 8453859     DOI： 10.1038/clpt.1993.37

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

Review 1.  Concentration-controlled or effect-controlled trials: useful alternatives to conventional dose-controlled trials?

Authors:  A Grahnén; M O Karlsson
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Pharmacokinetic-pharmacodynamic guided trial design in oncology.

Authors:  Ch van Kesteren; R A A Mathôt; J H Beijnen; J H M Schellens
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

3.  Randomized exposure-controlled trials; impact of randomization and analysis strategies.

Authors:  Kristin E Karlsson; Anders Grahnén; Mats O Karlsson; E Niclas Jonsson
Journal:  Br J Clin Pharmacol       Date:  2007-04-10       Impact factor: 4.335

4.  Drug distribution. The forgotten relative in clinical pharmacokinetics.

Authors:  H G Eichler; M Müller
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

5.  Feasibility of effect-controlled clinical trials of drugs with pharmacodynamic hysteresis using sparse data.

Authors:  W F Ebling; Y Matsumoto; G Levy
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

Review 6.  Concentration-controlled trials. What does the future hold?

Authors:  A Johnston; D W Holt
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 7.  The target concentration approach to clinical drug development.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

8.  Adaptive trials in paediatric development: dealing with heterogeneity and uncertainty in pharmacokinetic differences in children.

Authors:  Massimo Cella; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

Review 9.  Paediatric labelling requirements. Implications for pharmacokinetic studies.

Authors:  J T Wilson; G L Kearns; D Murphy; S J Yaffe
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.